George Frodsham

Tensys Medical, Inc. develops blood pressure monitoring systems. The firm provides patient safety by designing, and manufacturing continuous, non-invasive hemodynamic monitoring systems. The company was founded in 1995 and is headquartered in San Diego, CA.

BioGenex Laboratories, Inc. provides solutions for automation of cell and tissue testing. It offers automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company was founded by Krishan L. Kalra and Satya Kalra in 1981 and is headquartered in Fremont, CA.

Medovate Ltd. provides advice and consultancy services for medical product development. It provide services to NHS organisations, such as expert advice, funding and support to NHS innovators to translate ideas into practice. The company also provides consultancy services to technology based companies looking to access the UK market. Health Enterprise East was founded in 2004 and is headquartered in Cambridge, the United Kingdom.

Mologic Ltd. provides immunoassay research and development services. It products include TIMP-1 lateral flow kit, TIMP-2 lateral flow kit, human A1AT lateral flow kit and fMLP ELISA kit. The company was founded by Paul J. Davis and Mark Davis in 2003 and is headquartered in Thurleigh, the United Kingdom.

Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom.

Health Enterprise East Ltd. is a British company that focuses on building the future of healthcare through technology innovation. The private company is based in Cambridge, UK. The company provides technology advisory and innovation management services to both industry and the NHS.

Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States.

Carbometrics Ltd. is a British company that specializes in developing a new glucose sensor chemistry using their proprietary biomimetic glucose binding molecules (GBM). The company is based in Bristol, UK. The company's mission is to help people with diabetes live more normal and longer lives by creating market-leading continuous glucose monitors (CGM). Carbometrics was founded in 2018 by Keith Joseph MacDonald, Anthony Davis, Harry Destecroix, and Andy Chapman. Andy Chapman has been the CEO since 2018.